Alpha-1 antitrypsin inhibits pertussis toxin
Journal of Biological Chemistry · 2024
DOI: 10.1016/j.jbc.2024.107950 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2024. Verfasst von Stefanie Lietz und 20 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Experimental and Clinical Pharmacology, Toxicology and Pharmacology of Natural Products, Ulm University Medical Center, Ulm, Germany. Hauptthemen laut MEDLINE: alpha 1-Antitrypsin, Pertussis Toxin, Whooping Cough, Bordetella pertussis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Ministry for Foreign Affairs, Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Pertussis (whooping cough) is a vaccine-preventable but re-emerging, highly infectious respiratory disease caused by Bordetella pertussis. There are currently no effective treatments for pertussis, complicating care for nonvaccinated individuals, especially newborns. Disease manifestations are predominantly caused by pertussis toxin (PT), a pivotal virulence factor classified as an ADP-ribosylating AB-type protein toxin. In this work, an unbiased approach using peptide libraries, bioassay-guided fractionation and mass spectrometry revealed α1-antitrypsin (α1AT) as a potent PT inhibitor. Biochemistry-, cell culture-, and molecular modeling-based in vitro experimentation demonstrated that the α1AT mode of action is based on blocking PT-binding to the host target cell surface. In the infant mouse model of severe pertussis, α1AT expression was reduced upon infection. Further, systemic administration of α1AT significantly reduced B. pertussis-induced leukocytosis, which is a hallmark of infant infection and major risk factor for fatal pertussis. Taken together our data demonstrates that α1AT is a novel PT inhibitor and that further evaluation and development of α1AT as a therapeutic agent for pertussis is warranted. Importantly, purified α1AT is already in use clinically as an intravenous augmentation therapy for those with genetic α1AT deficiency and could be repurposed to clinical management of pertussis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Experimental and Clinical Pharmacology, Toxicology and Pharmacology of Natural Products, Ulm University Medical Center, Ulm, Germany.
- Core Facility Functional Peptidomics, Faculty of Medicine, Ulm University, Ulm, Germany; Core Unit Mass Spectrometry and Proteomics, Faculty of Medicine, Ulm University, Ulm, Germany.
- Core Facility Functional Peptidomics, Faculty of Medicine, Ulm University, Ulm, Germany.
- Biochemistry and Molecular Biology Department, Center for Pharmaceutical Research and Development, Nuevo Vedado, Cuba.
- Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
- Institute of Biophysics, Ulm University, Ulm, Germany.
Förderung
- NIAID NIH HHS
- Ministry for Foreign Affairs
- Deutsche Forschungsgemeinschaft
- European Social Fund Plus
- National Institute of Allergy and Infectious Diseases
- National Institutes of Health
- Ministerium für Wissenschaft, Forschung und Kunst Baden-Württemberg
- Deutscher Akademischer Austauschdienst
Zitieren
APA
Lietz, S., Sommer, A., Sokolowski, L. M., Kling, C., Rodríguez Alfonso, A. A., Preising, N., Alpízar-Pedraza, D., King, J., Streit, L., Schröppel, B., van Erp, R., Barth, E., Schneider, M., Münch, J., Michaelis, J., Ständker, L., Wiese, S., Barth, H., Pulliainen, A. T., …, & Ernst, K. (2024). Alpha-1 antitrypsin inhibits pertussis toxin. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2024.107950
Vancouver
Lietz S, Sommer A, Sokolowski LM, Kling C, Rodríguez Alfonso AA, Preising N, et al. Alpha-1 antitrypsin inhibits pertussis toxin. Journal of Biological Chemistry. 2024. doi:10.1016/j.jbc.2024.107950
BibTeX
@article{Lietz2024,
author = {Lietz, Stefanie and Sommer, Anja and Sokolowski, Lena-Marie and Kling, Carolin and Rodríguez Alfonso, Armando A and Preising, Nico and Alpízar-Pedraza, Daniel and King, Jaylyn and Streit, Lisa and Schröppel, Bernd and van Erp, Rene and Barth, Eberhard and Schneider, Marion and Münch, Jan and Michaelis, Jens and Ständker, Ludger and Wiese, Sebastian and Barth, Holger and Pulliainen, Arto T and Scanlon, Karen and Ernst, Katharina},
title = {Alpha-1 antitrypsin inhibits pertussis toxin},
journal = {Journal of Biological Chemistry},
year = {2024},
doi = {10.1016/j.jbc.2024.107950}
}
EUVIMED